Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from The Medicines and Healthcare products Regulatory Agency

Shop-bought health tests not always fit for purpose, researchers warn

The Medicines and Healthcare products Regulatory Agency said it would look at the findings.

The Independent UK

Patients on common blood pressure drug urged to check pack amid labelling error

More than 7,700 packs are affected by the recall, according to the Medicines and Healthcare products Regulatory Agency.

The Independent UK

Advertising regulator launches nine investigations into weight loss jab ads

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued warning to advertisers for drugs including Ozempic and Wegovy

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

The Independent UK

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Independent UK

New MedTech Funding To Predict Diseases And Make Treatments Available To UK Patients

The UK government has awarded medtech funding to eight UK medtech companies which are developing pathbreaking tests and AI detection tools for faster treatment of life-threatening diseases, reducing the burden of NHS.

International Business Times UK

‘Life-changing’ cystic fibrosis drugs approved for use in younger children

Campaigners welcomed the announcement by the Medicines and Healthcare Products Regulatory Agency.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

More babies will need hospital treatment over RSV vaccine delay, says top doctor

The Medicines and Healthcare products Regulatory Agency (MHRA) approved GSK’s jab, known as Arexvy, for use among older adults in July.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Birmingham

78 stories

MedTech

58 stories

the Advertising Standards Authority

48 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.